Subsequently, CCK-8 and transwell assay demonstrated that knockdown of MMP11 significantly reduced cell proliferation and invasion of SW1990 cell lines in vitro, suggesting MMP11 might provide new therapeutic target for the treatment of pancreatic cancer. This evidence concerns the gene MMP11 and pancreatic neoplasm.